Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4828-4837

  Kamath, Arun T ^a,b   Mastelic, Béatris ^a,b   Christensen, Dennis ^c   Rochat, Anne Françoise ^a,b   Agger, Else Marie ^c   Pinschewer, Daniel D ^a,b   Andersen, Peter ^c   Lambert, Paul Henri ^a,b   Siegrist, Claire Anne ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL SYNCHRONIZATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME KINETICS; FEMALE; FLOW CYTOMETRY; IMMUNOGENICITY; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TH1 CELL; TH17 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT FUSION PROTEINS; TH1 CELLS; TH17 CELLS; TUBERCULOSIS VACCINES;

EID: 84861138889     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103183     Document Type: Article

References (65)

1. Plotkin, S. A. 2010. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17: 1055-1065.
2. Bines, J. 2006. Intussusception and rotavirus vaccines. Vaccine 24: 3772-3776.
3. Coffman, R. L., A. Sher, and R. A. Seder. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503.
4. Pulendran, B., and R. Ahmed. 2011. Immunological mechanisms of vaccination. Nat. Immunol. 12: 509-517.
5. Guy, B. 2007. The perfect mix: recent progress in adjuvant research. Nat. Rev. Microbiol. 5: 505-517. (Pubitemid 46925379)
6. Leroux-Roels, G. 2010. Unmet needs in modern vaccinology: adjuvants to improve the immune response. Vaccine 28(Suppl 3): C25-C36.
7. Murphy, K. M., and B. Stockinger. 2010. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 11: 674-680.
8. Palucka, K., J. Banchereau, and I. Mellman. 2010. Designing vaccines based on biology of human dendritic cell subsets. Immunity 33: 464-478.
9. Tighe, H., K. Takabayashi, D. Schwartz, G. Van Nest, S. Tuck, J. J. Eiden, A. Kagey-Sobotka, P. S. Creticos, L. M. Lichtenstein, H. L. Spiegelberg, and E. Raz. 2000. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J. Allergy Clin. Immunol. 106: 124-134. (Pubitemid 30482862)
10. Kastenmüller, K., U. Wille-Reece, R. W. B. Lindsay, L. R. Trager, P. A. Darrah, B. J. Flynn, M. R. Becker, M. C. Udey, B. E. Clausen, B. Z. Igyarto, et al. 2011. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J. Clin. Invest. 121: 1782-1796.
11. Huleatt, J. W., A. R. Jacobs, J. Tang, P. Desai, E. B. Kopp, Y. Huang, L. Song, V. Nakaar, and T. J. Powell. 2007. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 25: 763-775. (Pubitemid 44856106)
12. Aebig, J. A., G. E. Mullen, G. Dobrescu, K. Rausch, L. Lambert, O. Ajose-Popoola, C. A. Long, A. Saul, and A. P. Miles. 2007. Formulation of vaccines containing CpG oligonucleotides and alum. J. Immunol. Methods 323: 139-146. (Pubitemid 46890965)
13. Didierlaurent, A. M., S. Morel, L. Lockman, S. L. Giannini, M. Bisteau, H. Carlsen, A. Kielland, O. Vosters, N. Vanderheyde, F. Schiavetti, et al. 2009. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol. 183: 6186-6197.
14. Wack, A., B. C. Baudner, A. K. Hilbert, I. Manini, S. Nuti, S. Tavarini, H. Scheffczik, M. Ugozzoli, M. Singh, J. Kazzaz, et al. 2008. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. Vaccine 26: 552-561.
15. Maubant, S., C. Banissi, S. Beck, A. Chauvat, and A. F. Carpentier. 2011. Adjuvant properties of cytosine-phosphate-guanosine oligodeoxynucleotide in combination with various polycations in an ovalbumin-vaccine model. Nucleic Acid Ther. 21: 231-240.
16. Lingnau, K., A. Egyed, C. Schellack, F. Mattner, M. Buschle, and W. Schmidt. 2002. Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines. Vaccine 20: 3498-3508. (Pubitemid 35248074)
17. Nordly, P., F. Rose, D. Christensen, H. M. Nielsen, P. Andersen, E. M. Agger, and C. Foged. 2011. Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method. J. Control. Release 150: 307-317.
18. Korsholm, K. S., E. M. Agger, C. Foged, D. Christensen, J. Dietrich, C. S. Andersen, C. Geisler, and P. Andersen. 2007. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology 121: 216-226. (Pubitemid 46663090)
19. + T cell populations lacking helper function. Nat. Immunol. 6: 163-170.
20. Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
21. Joffre, O., M. A. Nolte, R. Spörri, and C. Reis e Sousa. 2009. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 227: 234-247.
22. Kamath, A. T., A. F. Rochat, D. Christensen, E. M. Agger, P. Andersen, P. H. Lambert, and C. A. Siegrist. 2009. A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PLoS ONE 4: e5771.
23. Agger, E. M., I. Rosenkrands, J. Hansen, K. Brahimi, B. S. Vandahl, C. Aagaard, K. Werninghaus, C. Kirschning, R. Lang, D. Christensen, et al. 2008. Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS ONE 3: e3116.
24. Kamath, A. T., M. P. Valenti, A. F. Rochat, E. M. Agger, K. Lingnau, A. von Gabain, P. Andersen, P. H. Lambert, and C. A. Siegrist. 2008. Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells. Eur. J. Immunol. 38: 1247-1256.
25. Barrios, C., P. Brawand, M. Berney, C. Brandt, P. H. Lambert, and C. A. Siegrist. 1996. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 26: 1489-1496. (Pubitemid 26229993)
26. +) regulatory T cells. Blood 115: 1958-1968.
27. + dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207: 189-206.
28. Guilliams, M., S. Henri, S. Tamoutounour, L. Ardouin, I. Schwartz-Cornil, M. Dalod, and B. Malissen. 2010. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur. J. Immunol. 40: 2089-2094.
29. + dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J. Immunol. 169: 2247-2252.
30. Asherson, G. L., and S. H. Stone. 1965. Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy. Immunology 9: 205-217.
31. Parish, C. R. 1996. Immune deviation: a historical perspective. Immunol. Cell Biol. 74: 449-456. (Pubitemid 26342130)
32. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779. (Pubitemid 32983013)
33. Bonifaz, L., D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig, and R. M. Steinman. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196: 1627-1638. (Pubitemid 36026474)
34. Steinman, R. M., and M. C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99: 351-358. (Pubitemid 34060366)
35. H)2 and tolerogenic responses. Nat. Immunol. 11: 647-655.
36. Dudziak, D., A. O. Kamphorst, G. F. Heidkamp, V. R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H. W. Lee, C. G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111. (Pubitemid 46196991)
37. Mukhopadhaya, A., T. Hanafusa, I. Jarchum, Y. G. Chen, Y. Iwai, D. V. Serreze, R. M. Steinman, K. V. Tarbell, and T. P. DiLorenzo. 2008. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl. Acad. Sci. USA 105: 6374-6379. (Pubitemid 351758353)
38. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1219-1227. (Pubitemid 43045633)
39. Hawiger, D., Y. Y. Wan, E. E. Eynon, and R. A. Flavell. 2010. The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness. Nat. Immunol. 11: 962-968.
40. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258: 1156-1159.
41. Ashour, H. M., and T. M. Seif. 2007. The role of B cells in the induction of peripheral T cell tolerance. J. Leukoc. Biol. 82: 1033-1039. (Pubitemid 350133498)
42. Pletinckx, K., B. Stijlemans, V. Pavlovic, R. Laube, C. Brandl, S. Kneitz, A. Beschin, P. De Baetselier, and M. B. Lutz. 2011. Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses. Eur. J. Immunol. 41: 3479-3494.
43. Rogers, P. R., and M. Croft. 1999. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance. J. Immunol. 163: 1205-1213. (Pubitemid 29352735)
44. Baaten, B. J., C. R. Li, M. F. Deiro, M. M. Lin, P. J. Linton, and L. M. Bradley. 2010. CD44 regulates survival and memory development in Th1 cells. Immunity 32: 104-115.
45. Motran, C. C., K. M. Molinder, S. D. Liu, F. Poirier, and M. C. Miceli. 2008. Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function. Eur. J. Immunol. 38: 3015-3027.
46. Devadas, S., J. Das, C. Liu, L. Zhang, A. I. Roberts, Z. Pan, P. A. Moore, G. Das, and Y. Shi. 2006. Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 25: 237-247. (Pubitemid 44224145)
47. Sharma, V., M. Delgado, and D. Ganea. 2006. Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors. J. Immunol. 176: 97-110. (Pubitemid 43023253)
48. Zhang, X., T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain. 1997. Unequal death in T helper cell (Th) 1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185: 1837-1849. (Pubitemid 27242205)
49. + T cell-mediated immunity. J. Exp. Med. 208: 1767-1775.
50. Ma, F., S. Xu, X. Liu, Q. Zhang, X. Xu, M. Liu, M. Hua, N. Li, H. Yao, and X. Cao. 2011. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat. Immunol. 12: 861-869.
51. Du, C., C. Liu, J. Kang, G. Zhao, Z. Ye, S. Huang, Z. Li, Z. Wu, and G. Pei. 2009. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 10: 1252-1259.
52. Li, L., H. H. Lee, J. J. Bell, R. K. Gregg, J. S. Ellis, A. Gessner, and H. Zaghouani. 2004. IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity 20: 429-440. (Pubitemid 38482121)
53. Hansen, B., M. Belfast, G. Soung, L. Song, P. M. Egan, R. Capen, H. Hogenesch, R. Mancinelli, and S. L. Hem. 2009. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response. Vaccine 27: 888-892.
54. Egan, P. M., M. T. Belfast, J. A. Giménez, R. D. Sitrin, and R. J. Mancinelli. 2009. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine. Vaccine 27: 3175-3180.
55. Romero Méndez, I. Z., Y. Shi, H. HogenEsch, and S. L. Hem. 2007. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. Vaccine 25: 825-833. (Pubitemid 44856127)
56. Noe, S. M., M. A. Green, H. HogenEsch, and S. L. Hem. 2010. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. Vaccine 28: 3588-3594.
57. Deenick, E. K., and C. S. Ma. 2011. The regulation and role of T follicular helper cells in immunity. Immunology 134: 361-367.
58. Markine-Goriaynoff, D., J. T. van der Logt, C. Truyens, T. D. Nguyen, F. W. Heessen, G. Bigaignon, Y. Carlier, and J. P. Coutelier. 2000. IFN-γ-independent IgG2a production in mice infected with viruses and parasites. Int. Immunol. 12: 223-230. (Pubitemid 30088315)
59. Jegerlehner, A., P. Maurer, J. Bessa, H. J. Hinton, M. Kopf, and M. F. Bachmann. 2007. TLR9 signaling in B cells determines class switch recombination to IgG2a. J. Immunol. 178: 2415-2420. (Pubitemid 46233441)
60. van Dissel, J. T., S. M. Arend, C. Prins, P. Bang, P. N. Tingskov, K. Lingnau, J. Nouta, M. R. Klein, I. Rosenkrands, T. H. Ottenhoff, et al. 2010. Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers. Vaccine 28: 3571-3581.
61. Agger, E. M., I. Rosenkrands, A. W. Olsen, G. Hatch, A. Williams, C. Kritsch, K. Lingnau, A. von Gabain, C. S. Andersen, K. S. Korsholm, and P. Andersen. 2006. Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31. Vaccine 24: 5452-5460. (Pubitemid 43831377)
62. Henriksen-Lacey, M., D. Christensen, V. W. Bramwell, T. Lindenstrøm, E. M. Agger, P. Andersen, and Y. Perrie. 2011. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N′,N′- Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-dioleoyl-3- trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses. Mol. Pharm. 8: 153-161.
63. Christensen, D., M. Henriksen-Lacey, A. T. Kamath, T. Lindenstrøm, K. S. Korsholm, J. P. Christensen, A. Rochat, P. H. Lambert, P. Andersen, C. A. Siegrist, et al. 2012. A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog. J. Control. Release. DOI: 10.1016/j.jconrel.2012.03.016.
64. Henriksen-Lacey, M., D. Christensen, V. W. Bramwell, T. Lindenstrøm, E. M. Agger, P. Andersen, and Y. Perrie. 2010. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J. Control. Release 145: 102-108.
65. Calabro, S., M. Tortoli, B. C. Baudner, A. Pacitto, M. Cortese, D. T. O'Hagan, E. De Gregorio, A. Seubert, and A. Wack. 2011. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29: 1812-1823.